Signos announced today that it launched its FDA-cleared over-the-counter glucose monitoring system for weight management.

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

Pleural Dynamics announced today that it completed enrollment in a post-market clinical study for its ACES system.

Irvine, California-based Edwards triggered the agreement to repurchase $500 million of its common stock. With this ...

Stimvia announced that it completed a clinical study of its peroneal electrical transcutaneous neurmodulation (peroneal eTNM) ...

Masimo (Nasdaq: MASI) announced today that it received FDA 510(k) clearance for expanded indications for its O3 regional ...

Align Technology (Nasdaq: ALGN) announced that it filed patent infringement lawsuits against Shanghai-based Angelalign ...